Earnings Feed
Start Free
Matinas BioPharma Holdings, Inc.·4

Jan 3, 4:06 PM ET

MANNINO RAPHAEL J 4

4 · Matinas BioPharma Holdings, Inc. · Filed Jan 3, 2020

Insider Transaction Report

Form 4
Period: 2020-01-01
Matinas BioPharma Holdings, Inc.MTNB
MANNINO RAPHAEL J
Chief Scientific Officer
Transactions
  • Other

    Common Stock, par value $0.0001 per share

    [F1]
    2019-06-21+2,000→ 1,426,565 total
  • Award

    Stock option (right to buy)

    [F2]
    2020-01-01+100,000→ 100,000 total
    Exercise: $2.27Exp: 2030-01-01→ Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]Stock dividend, payable to all holders of records of Series B Preferred Stock of 200 shares of Common Stock for each share of Series B Preferred Stock.
  • [F2]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2021 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2021.
Signature
/s/ Keith A. Kucinski, attorney in fact for Raphael J. Mannino|2020-01-03

Documents

2 files